Loading
Cardiovascular Disease and Adiposity · Journal article
International Journal of Molecular Sciences · September 8, 2026
Raises a question worth testing. It does not answer one.
This narrative review examines the relationship between obesity, intrapancreatic fat depots, and pancreatic ductal adenocarcinoma risk, concluding that intrapancreatic fat is biologically plausible as a mediator of pancreatic carcinogenesis. The evidence presented is conceptual and mechanistic rather than definitive, and the authors explicitly call for prospective investigation to establish causality.
Narrative review. Patients with pancreatic ductal adenocarcinoma; general population at risk for PDAC.
Obesity has emerged as a major modifiable risk factor for PDAC Intrapancreatic fat is identified as a potential mediator linking metabolic disease to pancreatic carcinogenesis Available evidence supports intrapancreatic fat as biologically plausible, warranting further prospective investigation
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This review identifies intrapancreatic fat as a potential mechanistic link between metabolic disease and pancreatic cancer, suggesting that metabolic interventions or imaging assessment of pancreatic fat may warrant future investigation. However, the evidence is not yet sufficient to guide clinical practice changes.
This is a narrative review summarizing existing evidence and proposing intrapancreatic fat as a biologically plausible mediator of pancreatic cancer risk, rather than presenting primary empirical evidence or a definitive causal relationship.
As stated by the source record.
This review identifies intrapancreatic fat as a potential mechanistic link between metabolic disease and pancreatic cancer, suggesting that metabolic interventions or imaging assessment of pancreatic fat may warrant future investigation. However, the evidence is not yet sufficient to guide clinical practice changes.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Pancreatic adenocarcinoma (PDAC) remains one of the most lethal malignancies worldwide, with limited improvements in long-term survival despite significant progress in systemic therapy. This review focuses predominantly on pancreatic ductal adenocarcinoma (PDAC), the most common and best-studied pancreatic malignancy, while referencing other pancreatic neoplasms only where directly relevant to intrapancreatic fat biology. Obesity has emerged as a major modifiable risk factor for PDAC. In addition, increasing attention has focused on ectopic fat depots, particularly intrapancreatic fat, as potential mediators linking metabolic disease to pancreatic carcinogenesis. This narrative review summarizes the classification and epidemiology of PDAC, the relationship between obesity and pancreatic cancer risk, the biology of intrapancreatic fat, as well as putative mechanisms by which intrapancreatic fat may promote pancreatic carcinogenesis. In addition, we will review current diagnostic approaches, therapeutic and preventive considerations, and key unanswered questions for future research on the relevance of intrapancreatic fat deposits. Collectively, available evidence supports intrapancreatic fat as a biologically plausible and potential mediator of pancreatic cancer risk, warranting further prospective investigation.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.